Literature DB >> 10730038

The Night Vision Threshold Test (NVTT): a simple instrument for testing dark adaptation in young children.

B Duncan1, L Canfield, B Barber, J Greivenkamp, F O Oriokot, F Naluyinda.   

Abstract

It is estimated that 41 per cent of the population aged under 5 in the developing world has an inadequate vitamin A dietary intake resulting in increased morbidity and mortality. Half a million children go blind each year as a result of vitamin A deficiency. Thirteen and a half million have night blindness, the first sign of vitamin A deficiency. Unfortunately, there is no simple, sensitive and inexpensive means to identify the child who has marginal levels of vitamin A and thus institute means to prevent their development of severe deficiency. A low cost, simple, easy-to-use instrument designed to detect a young child's ability to adapt to darkness was tested in children admitted to the Mwanamugimu Nutrition Unit at Makerere Medical School in Kampala, Uganda. Despite the severe degree of malnutrition found in these children, Night Vision Threshold Test results and serum retinol levels were related (r = 0.41, p < 0.05). Further efficacy trials for this instrument are planned at community sites in Nepal.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10730038     DOI: 10.1093/tropej/46.1.30

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  2 in total

1.  Changes in Vitamin A Levels and the Effect of Early Vitamin A Supplementation on Vitamin A Levels in Infants Throughout the First 6 Months of Life: A Prospective Cohort Study in Chongqing, China.

Authors:  Huan Liu; Qixiong Chen; Linchao Yu; Ting Yang; Jie Chen; Jingkun Miao; Tingyu Li
Journal:  Front Public Health       Date:  2021-04-27

2.  Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda.

Authors:  Hanifa Bachou; Thorkild Tylleskär; Deogratias H Kaddu-Mulindwa; James K Tumwine
Journal:  BMC Infect Dis       Date:  2006-11-07       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.